- CA$5.66m
- CA$5.54m
- CA$1.18m
- 42
- 20
- 52
- 32
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 0.986 | 1.19 | 1.48 | 1.13 | 1.18 |
Cost of Revenue | |||||
Gross Profit | 0.695 | 0.867 | 1.12 | 0.78 | 0.812 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 1.03 | 1.08 | 1.13 | 1.27 | 1.46 |
Operating Profit | -0.043 | 0.109 | 0.354 | -0.14 | -0.278 |
Total Net Non Operating Interest Income / Expense | |||||
Net Income Before Taxes | -0.049 | 0.106 | 0.367 | -0.137 | -0.158 |
Net Income After Taxes | -0.049 | 0.106 | 0.367 | -0.137 | -0.158 |
Net Income Before Extraordinary Items | |||||
Net Income | -0.049 | 0.106 | 0.367 | -0.137 | -0.158 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -0.049 | 0.106 | 0.367 | -0.137 | -0.158 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.001 | 0.001 | 0.007 | -0.004 | -0.004 |